Clinical Trials Logo
  1. Home
  2. End Stage Renal Disease
  3. NCT00431899
  4. Details
NCT00431899 Clinical Trial

Effects of Omega 3 in Hemodialysis Patients

End Stage Renal Disease Clinical Trial

Official title:
Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00431899
Other study ID # HDW3
Secondary ID
Status Completed
Phase N/A
First received February 3, 2007
Last updated March 2, 2016
Start date May 2003
Est. completion date November 2003

Study information
Verified date February 2007
Source Laboratoire Régional de Nutrition Humaine
Contact n/a
Is FDA regulated No
Health authority France: Ministry of Health
Study type Interventional

Clinical Trial Summary

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Recruitment information / eligibility
Status Completed
Enrollment 8
Est. completion date November 2003
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- hemodialysis at least 6 months duration end stage renal disease

Exclusion Criteria:

- - Age < 18 y ou > 75 y

- Hemodialysis < 6 months

- Diabetes, obesity

- allergy to fish

- Asthma

- glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin

- erythropoïetin < 3 months

- Cancer

- Hemoglobin < 11 g/l

- disease < 1 month

- pregnancy

- respiratory insufficiency

- intensive sport practice

- refusal

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

Related Conditions & MeSH terms

Intervention

Behavioral:
• fish oil supplementation

Locations
Country Name City State
France Laboratoire Régional de Nutrition Humaine Brest

Sponsors (1)
Lead Sponsor Collaborator
Laboratoire Régional de Nutrition Humaine

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary plasma glucose utilization
Primary glucose-induced thermogenesis
See also
  Status Clinical Trial Phase
Completed NCT04076488 - Feasibility of an Interactive Tablet-based Exercise Program for People With Chronical Diseases N/A
Completed NCT03289650 - Extended Release Tacrolimus vs. Twice-Daily Tacrolimus Phase 3
Completed NCT04042324 - A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients Phase 1/Phase 2
Completed NCT01242904 - Use of a Bimodal Solution for Peritoneal Dialysis Phase 2
Active, not recruiting NCT03183245 - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Phase 3
Completed NCT03257410 - Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients N/A
Completed NCT03627299 - Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors Phase 4
Recruiting NCT05917795 - Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates N/A
Terminated NCT03539861 - Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients N/A
Withdrawn NCT02130817 - Belatacept in Kidney Transplantation of Moderately Sensitized Patients Phase 4
Completed NCT05540457 - Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis) N/A
Not yet recruiting NCT04900610 - The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis N/A
Recruiting NCT02176434 - Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease N/A
Active, not recruiting NCT02581449 - Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis Phase 2
Completed NCT02134314 - C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI Phase 1/Phase 2
Completed NCT02832440 - Comparison of Two Exercise Programmes in Patients Undergoing Hemodialysis N/A
Completed NCT02215655 - Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence N/A
Completed NCT02832466 - Quantifying the Deterioration of Physical Function in Renal Patients N/A
Completed NCT02830490 - Reliability of Functional Measures in Hemodialysis Patient. N/A
Recruiting NCT01912001 - Virtual Ward for Home Dialysis N/A